» Articles » PMID: 1362888

Effect of 3 Weeks Treatment with Yohimbine on Salivary Secretion in Healthy Volunteers and in Depressed Patients Treated with Tricyclic Antidepressants

Overview
Specialty Pharmacology
Date 1992 Dec 1
PMID 1362888
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of yohimbine treatment (4 mg three times daily) for 3 weeks on salivary secretion was investigated. In healthy volunteers, acute administration of yohimbine increased salivary volume within 1 h to a similar extent before and at the end of the treatment period. In depressed patients treated with tricyclic antidepressants (and exhibiting a reduced salivary flow), yohimbine also acutely increased salivary volume. In contrast, the alpha 2-adrenoceptor antagonist failed to modify resting values measured in the morning (i.e. 10 and 14 h after the last administration in healthy volunteers and depressed patients respectively). This result indicates that alpha 2-adrenoceptor antagonists may have a potential therapeutic use in the treatment of dry mouth caused by tricyclic antidepressant drugs.

Citing Articles

A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of Aqualief Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.

Iacovelli N, Ingargiola R, Facchinetti N, Franceschini M, Romanello D, Bossi P Cancers (Basel). 2021; 13(14).

PMID: 34298670 PMC: 8303446. DOI: 10.3390/cancers13143456.


Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farre M Int J Med Sci. 2015; 12(10):811-24.

PMID: 26516310 PMC: 4615242. DOI: 10.7150/ijms.12912.


Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

Bagheri H, Picault P, Schmitt L, Houin G, Berlan M, Montastruc J Br J Clin Pharmacol. 1994; 37(1):93-6.

PMID: 8148228 PMC: 1364719. DOI: 10.1111/j.1365-2125.1994.tb04248.x.

References
1.
Blackwell B, Stefopoulos A, Enders P, Kuzma R, Adolphe A . Anticholinergic activity of two tricyclic antidepressants. Am J Psychiatry. 1978; 135(6):722-4. DOI: 10.1176/ajp.135.6.722. View

2.
Girolami J, Bascands J, Pecher C, Berlan M, Montastruc J, MONTASTRUC P . Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways. Br J Pharmacol. 1991; 102(2):351-4. PMC: 1918049. DOI: 10.1111/j.1476-5381.1991.tb12177.x. View

3.
Rispail Y, Schmitt L, Berlan M, Montastruc J, MONTASTRUC P . Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants. Eur J Clin Pharmacol. 1990; 39(4):425-6. DOI: 10.1007/BF00315426. View

4.
MONTASTRUC P, Berlan M, Montastruc J . Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol. 1989; 98(1):101-4. PMC: 1854671. DOI: 10.1111/j.1476-5381.1989.tb16868.x. View

5.
Owen J, Nakatsu S, Fenemore J, Condra M, SURRIDGE D, Morales A . The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol. 1987; 32(6):577-82. DOI: 10.1007/BF02455991. View